Abstract Purpose: To detect and characterize mesenteric lymphadenopathy using multi-detector CT. Patients and methods: This prospective study included 100 patients with abdominal pain or mass. MDCT examination of the abdomen was performed for all the patients using 16-detector MDCT scanner (Bright Speed 16; GE medical systems). The axial and MPR images were interpreted for nodal size, morphology, number, distribution, and associated groups of LN. Histopathological examination of the biopsied nodes was performed for confirmation. Results: Based on nodal size criterion, nodes were classified into two groups: normal in 68% and pathologic in 32%. Most of normal nodes were oval shape (88.2%), multiple (85%) and located at the root of the mesentery (70.6 %). Most of pathologic nodes were well-defined (62.5%), rounded shape (37.5%) with lobulated margins (43.75%). They were multiple (68.7%), located at the root of the mesentery (87.5 %) and enhanced (75%). Central necrosis was detected in 6 patients, calcification in 5 patients and extra-nodal spread in 12 patients. The associated other groups of abdominal lymph node enlargement were detected in 26 patients. Conclusion: The MDCT has a great role in characterization of mesenteric lymph node which helps in differentiation between normal and pathological groups based on many MDCT criteria.
Introduction
Mesenteric lymph nodes are the 100-150 lymph nodes that lie between layers of the mesentery that accompany the branches of the superior mesenteric artery and vein and are located within the mesenteric fat (1) . Normal mesenteric lymph nodes may be routinely identified at the mesenteric root and throughout mesentery in particular; at Rt. iliac fossa in children (2) and at the mesenteric root in adults (3) .
There are a large number of disease processes that may lead to mesenteric lymphadenopathy. The most common causes of mesenteric lymphadenopathy are neoplastic, inflammatory, and infectious (4) .
With the advent of multi-detector computed tomography (MDCT) routine evaluation of mesenteric lymph nodes is now possible. With the increasing volume of cross-sectional imaging being performed, lymph nodes in the mesentery are being detected with increasing frequency (4) .
Normal mesenteric lymph node appears as round or oval soft tissue masses that appear and disappear over several images and enhances slightly more than the adjacent muscle on CT (4) . Mesenteric lymph nodes with a mean maximum short-axis dimension of 4.6 mm are considered normal at CT (3) .
The most widely accepted and frequently used criterion for determination of nodal involvement is the size criterion (5) . In addition, it is important to remember that the size of the nodes alone does not always reflect disease, but morphology, number and distribution of lymph nodes are also important (3) .
So the aim of our study was detection and characterization of mesenteric lymphadenopathy using multi-detector computed tomography.
Patients and methods

Patients
This study was approved by the ethics committee of our institution during the period between March 2014 and July 2015, and all the patients had an informed consent. This study included 100 patients referred from the oncology and surgery clinics. They were either complained of abdominal pain or abdominal mass or incidentally presented for other investigations. Their ages ranged from 20 to 73 with a mean value of 51.22 ± 25.6 years. They were fifty-eight males (58%) and forty-two females (42%).
Technique of MDCT abdomen
Patient preparation
All the patients were given 1000 ml of oral contrast agent [1-2% diluted water soluble iodinated contrast agent, meglumine diatrizoate (Gastrografin)] 2-h before the examination, provided that patients were fasting for 6 h.
Imaging acquisition and scanning parameters
MDCT examination of the abdomen and pelvis was performed for all the patients using 16-detector MDCT scanner (Bright Speed 16; GE medical systems). The examination included unenhanced and enhanced scans. The unenhanced scan was performed to detect calcified mesenteric lymph node. The post contrast study was performed after intravenous bolus injection of 80 ml of nonionic contrast agent (300 mg/mL, Omnipaque 300) at a flow rate of 4 ml/s using power injector (Medrad, Stellant) through 20 gauge catheter into the anti-cubital vein using time bolus tracking technique. Imaging was performed during the portal venous phase with a delay of 60-70 s used in all cases. The images were obtained from the level of the dome of diaphragm to the symphysis pubis. The axial source images were taken at a 1.25 mm section thickness and a 1.25 mm interval with the following acquisition scanning parameters: 420 mAs, 100 kVp, 12.7 s total exposure time, a helical pitch of 1.375:1, 0.8 s scan time, 16 Â 1.25 mm detector configuration.
Image reconstruction
The axial source images with a 1.25 mm slice thickness were transferred to an Advantage workstation (AW) volume share 2 (GE Healthcare) for image reconstructions. Multi-planner reformatted images were obtained in coronal and sagittal planes with a section thickness of 1.25 mm.
Imaging analysis
The nodes were classified into two groups (normal and pathologic) according to the size criterion with a mean maximum short-axis dimension of 4.6 mm which was considered the cutoff value above which the nodes were considered pathologic, and this was based on the previous study of Lucey et al. (3) . Besides the size criterion, all the MDCT images were interpreted for the other MDCT criteria of mesenteric LN including the following:
-Morphology (definition, margin, shape) -Enhancement pattern -Calcification -Central necrosis -Extra nodal spread -Distribution -Number -Associated other groups of abdominal LN.
Biopsy and histopathological examination
Biopsy was performed for all the thirty-two patients with mesenteric lymph node enlargement (pathologic group). They were subjected to biopsy procedures in the form of fine needle aspiration for 9 patients, true cut needle biopsy for 15 patients, and excisional biopsy for 8 patients. Pathological examination of the biopsied specimen was performed for confirmation of the pathologic cause.
Statistical analysis
Data entry was done by SPSS version 11. Frequency distribution, descriptive statistics and correlation analysis were done using v 2 and Fisher exact tests for qualitative data. The probability (p value) of less than 0.05 is used as a cutoff point for all significant tests. The sensitivity, specificity, PPV, NPV and accuracy of MDCT in differentiating benign from malignant lymph nodes were calculated.
Results
Based on nodal size criterion (cutoff value of 4.6 mm), we found that normal mesenteric lymph nodes were encountered in 68 (68%) out of 100 patients and pathologically enlarged mesenteric lymph nodes were encountered in 32 (32%) out of 100 patients ( Table 1 ). The size of normal mesenteric nodes ranged from 1.0 mm to 4.6 mm with a mean value of 2.96 mm (Fig. 1) , while the size of pathologic mesenteric nodes ranged from 4.7 mm to 9 cm with a mean value of 19 mm. There was a statistically significant difference between the size of normal and pathologically enlarged mesenteric lymph nodes (p = 0.02) ( Table 2) .
Regarding the MDCT criteria of normal mesenteric lymph node group we found that, most of normal mesenteric lymph nodes were oval shape, as they were encountered in 60 (88.2%) out of 68 patients, multiple in number representing 58 (85%) out of 68 patients and located at the root of the mesentery representing 48 (70.6%) out of 68 patients (Table 3) .
According to The MDCT criteria of the pathologic mesenteric lymph node group (n = 32) we determined that most of the pathologic mesenteric LN were well defined (62.5%), rounded in shape (37.5%) with lobulated margins (43.75%). Most of the detected pathologic mesenteric lymph nodes were multiple in number encountered in 22 (68.7%) out of 32 patients and located at the root of the mesentery in 28 (87.5%) out of 32 patients. Most of them were enhanced representing 75%, they exhibit different enhancement patterns, the most common pattern was homogenous enhancement which was encountered in 14 (58.3%) out of 24 patients. Central necrosis was detected in 6 (42.8%) out of 14 patients with metastatic nodes and calcification was noted only in 5 (15.6%) out of 32 patients. One of the important MDCT criteria was the demonstration of extra-nodal spread in the form of a) encasement of mesenteric vessels in 8 (66.7%) out of 12 patients and b) invasion of mesenteric vessels in 4 (33.3%) out of 12 patients. The last MDCT criteria was the association of other groups of abdominal lymph node enlargement that was detected in 26 (81.2%) out of 32 patients (Table 4) .
According to pathological verification, the causes of enlarged mesenteric LN (n = 32) were classified into nonneoplastic and neoplastic causes. Non-neoplastic causes were detected in 6 (18.75%) out of 32 patients, and they were further classified into inflammatory causes included appendicitis, Crohn's disease, and proctocolitis and infectious causes in the form of TB. Neoplastic causes were detected in 26 (81.25%) out of 32 patients, and the most common neoplastic cause was lymphoma as it was detected in 12 (46.2%) out of 26 patients. Other neoplastic causes are enumerated in Table 5 (Figs. 2-5). MDCT was accurate (83.6%) in differentiating benign from malignant lymph nodes with a sensitivity of (72.6%) and specificity of (68.3%) Table 6 .
Discussion
It is important to recognize mesenteric lymphadenopathy in patients with history of primary carcinoma because lymphadenopathy affects staging of the disease, which in turn will affect further management. In addition, mesenteric lymphadenopathy may be the only indicator of an underlying inflammatory or infectious process causing abdominal pain (4).
In our study the mesenteric lymph nodes were classified into normal and pathological groups according to the size criterion which is the most important morphological feature, 4.6 mm was the cutoff value used for distinguishing between normal sized and enlarged mesenteric lymph nodes, and this was based on the previous report documented by Lucey et al. (3) . According to size criterion our results revealed that normal mesenteric lymph nodes were encountered in 68 (68%) out of 100 patients and pathologically enlarged mesenteric lymph nodes were encountered in 32 (32%) out of 100 patients. There was a statistically significant difference between the size of normal and pathologically enlarged mesenteric lymph nodes (p = 0.02). The mean maximum short axis diameter of normal mesenteric lymph was 2.96 mm and ranged from 1.0 mm to 4.6 mm while that of the pathologic nodes was 19 mm and ranged from 4.7 mm to 9 cm, and these measures were based on and in accordance with Lucey et al. (3) who estimate the mean size of mesenteric lymph nodes in 47 patients who were presented to the emergency department after experiencing blunt abdominal trauma; the mean size of the largest nodes was 4.8 mm (range, 3-9 mm). Pathological group of mesenteric nodes may reach very large size as they are matted together forming huge nodal mass as in case of lymphoma and TB (6) .
The main drawbacks depending upon the size criterion alone were addressed by Sahani (5) who reported that the major limitation of this criterion is the inability to detect metastatic involvement in normal-sized nodes and inability to differentiate reactive and hyperplastic nodal enlargement from malignant nodes. These drawbacks may lead to underestimating or overestimating the presence of the disease. So depending on other MDCT criteria such as number and distribution combined with size criterion is ideal for better differentiation.
The incidence (68%) of normal sized mesenteric lymph node in this study was higher than that of Lucey et al. (3) which was 39%, and this can be explained by that all our CT examinations were performed using a 16-detector with a thinner section thickness of 1.25 mm and a reconstruction interval of 1.25 mm, which permits more frequent detection of small lymph nodes compared with Lucey study (3) in which all the CT examinations were performed using a 4-MDCT scanner with a slice collimation of 3.2 mm, and a reconstruction interval of 3 mm. The MDCT criteria of normal nodes included the shape, enhancement pattern, number and distribution. The result of this study revealed that most of lymph nodes were oval in shape representing (88.2%) this was in (7) who reported that normal lymph node tends to be oval in shape while metastatic lymph node is rounded. The normal nodes were multiple representing 85.3%, which is in agreement with Lucey et al. (3) who reported that, in healthy population, when mesenteric lymph nodes are present, they are usually multiple, with nearly half (47%) of these patients having five or more nodes detected. He also addressed that small lymph nodes are frequently detected (68%) at the mesenteric root, and we also found that most of normal nodes (70.6%) are distributed in the root of mesentery. According to MDCT criteria of pathological mesenteric lymph node group, that was presented in (32%), we determined that most of our patients have well defined (62.5%), lobulated (43.75%) and amalgamated (37.5%) mesenteric lymph node and this was attributed to the fact that the most common pathologic cause in this study was lymphoma (46.2%), which was in comparable with Lucey et al. (4) who reported that the mesenteric lymph nodes which were affected by lymphoma often coalesce, forming a conglomerate lobulated soft-tissue mass. We also found that most of pathologically enlarged mesenteric lymph nodes attain rounded shape representing 37.5% and this was explained by the fact that 14 out of 26 patients with neoplastic causes of LN enlargement had metastatic nodes, which was in accordance with Som and Brandwein (7) who reported that most of metastatic nodes were rounded in shape.
Nodal enhancement seems to imply increased nodal vascularity. At MDCT, the appearance of mesenteric nodes after contrast material administration may aid in identifying the underlying cause, although the enhancement patterns of different entities can overlap and suggest wide differential diagnosis (8) . In this study the most common pattern of enhancement was homogenous enhancement (58.3%) and this can be attributed to lymphoma (46.2%) which is the most common pathology in our study. Pombo et al. (9) and Hopper et al. (10) also reported that lymphoma is the commonest malignant pathology that affects the mesentery, which shows homogenous enhancement on post-contrast CT.
The best radiological predictor of lymph node metastasis is central necrosis. In our study, central necrosis with peripheral enhancement was detected in 6 (42.8%) out of 14 patients with The extra nodal spread is a grave prognostic finding. In our study the extra nodal spread was detected in 12 (37.5%) out of 32 patients in the form of encasement of mesenteric vessels which was detected in 8 (66.7%) out of 12 patients and invasion of mesenteric vessels that was detected in 4 (33.3%) out of 12 patients. Encasement of superior mesenteric artery forms a characteristic sign which is ''sandwich-sign". It was created by the lobulated, confluent mesenteric soft-tissue masses that resemble two halves of a sandwich and the tubular structures of mesenteric vessels and perivascular fat that resembles the sandwich filling. This sign is usually seen in patients with lymphoma of the mesentery. Mueller et al. (12) and Yang et al. (13) also postulated that neoplastic involvement of the mesentery can be diagnosed in lymphoma on the basis of a characteristic appearance of ''sandwich-sign" encasement of the superior mesenteric artery. The second pattern of extra-nodal spread was the invasion to mesenteric vessels that was identified on contrast-enhanced CT by thickened nodal rim with infiltration of the adjacent plane. This was a) . This is associated with multiple enlarged mesenteric and para-aortic lymph nodes (white arrow in b), they show central necrosis and peripheral enhancement. Histopathologically proved to be colonic carcinoma with nodal metastases. based on Som and Brandwein (7) who postulated that such extra-nodal spread is less reliably identified in MRI than in CT. This may simply be due to the fact that the low attenuation of fat on CT is the best background to identify such early nodal changes. The last MDCT criterion that was evaluated in our study was the association of other groups of abdominal lymph nodes enlargement; we found that most of mesenteric LN enlargements were associated with peri-pancreatic, para-aortic, retroperitoneal and iliac lymph nodes, representing 81.2%. This can be explained by the fact that the mesenteric lymphadenopathy rarely presents alone whatever its pathologic causes as lymphoma, TB, and metastasis from primary tumors. In this study 12 (46.2%) out of the 26 patients had lymphoma, and multiplicity of abdominal lymph nodal enlargement with lymphoma was also addressed by Yenarkan et al. (14) who reported that the clue for diagnosis of lymphoma of the mesentery was the prominent mesenteric lymphadenopathy associated with other groups mostly retroperitoneal lymph nodes.
According to the pathological examination the enlarged mesenteric lymph nodes were classified into non-neoplastic and neoplastic causes. In our study, non-neoplastic nodes were detected in 6 (18.75%) out of 32 patients. Neoplastic causes were detected in 26 (81.25%) out of 32 patients; they were classified into Lymphoma and metastasis from primary tumors such as colonic carcinoma (15.3%), breast carcinoma (15.3%). In this study the most common malignant cause affecting the mesenteric lymph node was lymphoma representing 46.2%, which was in agreement with many previous studies as Cole (15) , Mueller et al. (12) , and Yang et al. (13) who reported that the most common malignancy resulting in mesenteric lymphadenopathy is lymphoma, and also it is the most common cause of mesenteric masses. Horton et al. (16) and Hardy et al. (17) also reported that most cases of mesenteric lymphadenopathy are associated with non-Hodgkin lymphoma rather than with epithelial tumors. Mesenteric involvement is the predominant finding in 4-5% of patients with Hodgkin lymphoma and in 30-50% of patients with non-Hodgkin lymphoma (18, 19) .
In this study the second most common malignant cause affecting mesenteric lymph nodes is metastasis from colonic (15.3%.) and breast carcinoma (15.3%). This was in agreement with other studies Hansen et al. (20) , Shirkhoda et al. (21) , and Chintapalli et al. (22) and they reported that primary malignancies that more commonly result in mesenteric lymphadenopathy include carcinoma of the breast (20) and gastrointestinal tract (21, 22) .
The overall diagnostic accuracy of MDCT in differentiating benign from malignant lymph nodes in our study was 83.6%; similar value was also reported by Kanamoto et al. (23) who concluded that the MDCT was effective for evaluation of lymph nodes metastasis of colorectal cancer with overall 80.5%. A recent study of Saito et al. (24) documented that the total accuracy of multidetector-row CT in diagnosing lymph node metastasis in patients with gastric cancer was 76.6%.
The main limitation of our study is that it relied mainly on the size criterion in differentiating normal from pathologic mesenteric lymph nodes, although it is the most widely used CT criteria; however, it had a major limitation which is its inability to detect metastasis in normal-sized nodes that may lead to understaging of the malignant diseases.
Conclusion
The MDCT has a great role in characterization of mesenteric lymph node which helps in differentiation between normal and pathologic mesenteric lymph nodes and between different causes of mesenteric nodal enlargement based on many MDCT criteria such as the morphology, distribution, and enhancement pattern that may give an indication of the underlying pathologic condition. So we recommend that whenever possible, MDCT examination should be performed prior to any nodal biopsy procedures.
